Toward an effective treatment for a major hereditary disease
Monday, October 13, 2008 - 09:42
in Health & Medicine
Scientists are reporting a key advance toward developing the first effective drug treatment for spinal muscular atrophy (SMA), a genetic disease that involves motor neuron loss and occurs in 1 out of every 6,000 births. SMA is the leading cause of hereditary infant death in the United States. The study is scheduled for publication online Oct. 8 by ACS Chemical Biology.
Read the whole article on Physorg
More from Physorg
Related
- Researchers identify drug candidate for treating spinal muscular atrophyWed, 4 Nov 2009, 15:44:09 EST
- Rare window on spinal muscular atrophy geneticsTue, 7 Apr 2009, 6:14:56 EDT
- ISU researchers find possible treatment for spinal muscular atrophyMon, 27 Jul 2009, 14:37:03 EDT
- Researchers discover target that could ease spinal muscular atrophy symptomsWed, 7 Jan 2009, 13:17:33 EST
- Penn researchers gain new insights on spinal muscular atrophyThu, 29 May 2008, 15:14:52 EDT